Press release
Continuous Glucose Monitoring Market Forecast 2035: Rising Diabetes Prevalence and Demand for Real-time Monitoring Propel Market Growth | Transparency Market Research, Inc
Continuous Glucose Monitoring Market
Access an overview of significant conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169
As the burden of diabetes continues to grow globally, CGM systems are increasingly recognized as essential tools for patients and clinicians to achieve tighter glucose control, reduce complications, and improve quality of life.
Market Introduction: Revolutionizing Diabetes Care with CGM
Continuous glucose monitoring represents a paradigm shift in diabetes management. Unlike conventional finger-stick tests, CGMs continuously measure glucose levels in the interstitial fluid through a sensor inserted under the skin. These readings are automatically transmitted to receivers or smartphone applications, providing patients and clinicians with dynamic, real-time data and actionable insights.
This round-the-clock monitoring empowers patients to understand how diet, exercise, stress, and medications affect their glucose trends, while also alerting them to dangerous episodes of hypoglycemia or hyperglycemia. For clinicians, CGMs enable data-driven treatment adjustments, ultimately supporting personalized and preventive care.
Modern CGM systems have evolved beyond standalone devices-they are now integral components of broader digital health ecosystems, supporting remote consultations, predictive analytics, and integrated diabetes management platforms.
Growing Demand for Remote Patient Monitoring and Telemedicine
The global shift toward remote healthcare delivery and telemedicine has significantly accelerated CGM adoption. As healthcare systems pivot to virtual care models, CGMs provide a reliable, real-time data stream that can be seamlessly shared with healthcare providers.
This integration brings multiple benefits:
Personalized care: Clinicians can monitor patients remotely, intervene when needed, and tailor therapy plans.
Convenience: Patients can manage diabetes from home without frequent clinic visits.
Cost-effectiveness: Reduced hospital admissions and emergency visits lower overall healthcare costs.
The COVID-19 pandemic further reinforced the value of remote monitoring, leading both providers and patients to embrace CGM systems as indispensable tools for modern diabetes care.
Technological Advancements in CGM Devices
Discover key insights by visiting our in-depth report - https://www.transparencymarketresearch.com/continuous-glucose-monitoring.html
Rapid technological innovation is reshaping the CGM landscape:
Improved sensors: Modern CGMs offer better accuracy, longer sensor lifespans, and minimally invasive designs.
Real-time connectivity: Seamless integration with smartphones, wearables, and cloud-based platforms.
AI and analytics: Advanced algorithms help identify trends, forecast glucose fluctuations, and generate actionable insights.
User-centric design: Customizable alerts and simplified interfaces enhance user adherence.
These advancements make CGMs not only easier to use but also more powerful as diagnostic and preventive tools. The convergence of AI, IoT, and data analytics is transforming CGMs into intelligent companions that support proactive diabetes management.
Sensor Component Dominates CGM Market
Among CGM components, the sensor segment holds the largest market share and remains the core driver of industry growth. Sensors continuously capture glucose levels with high precision, enabling real-time monitoring.
Key factors fueling this dominance include:
Technological improvements that extend sensor life and reduce calibration needs.
The rise of implantable and minimally invasive sensors, enhancing comfort and long-term use.
Integration with predictive analytics to provide early warnings for abnormal glucose fluctuations.
As user trust in sensor accuracy grows, these components will remain central to CGM innovation and market expansion.
Regional Outlook: North America Maintains Leadership
North America is projected to retain its position as the leading region in the global CGM market. Several factors contribute to this dominance:
High diabetes prevalence and growing awareness about continuous monitoring.
Advanced healthcare infrastructure and regulatory frameworks that support innovation.
Presence of leading CGM manufacturers such as Dexcom, Medtronic, and Abbott driving R&D investments.
The U.S. and Canada also benefit from integration of CGMs into telemedicine and insurance reimbursement models, further encouraging adoption.
Meanwhile, regions like Europe and Asia Pacific are witnessing significant growth:
Europe benefits from strong regulatory support and widespread awareness.
Asia Pacific sees rising demand driven by an increasing diabetic population, urbanization, and government initiatives in digital health.
Competitive Landscape and Key Developments
The CGM market is characterized by innovation and strategic launches by industry leaders. Prominent players include:
Dexcom, Inc.
Abbott
Medtronic
Ypsomed AG
Senseonics Holdings, Inc.
A. Menarini Diagnostics S.r.l.
Signos, Inc.
F. Hoffmann-La Roche Ltd
Nemaura
Bionime Corporation
Intelligo BV
Want to know more? Get in touch now. -https://www.transparencymarketresearch.com/contact-us.html
Recent market developments highlight ongoing innovation:
In February 2025, Dexcom, Inc. launched Dexcom ONE+ in Spain, Belgium, and Poland, a customizable CGM solution featuring wearable sensors and smartphone integration.
In January 2024, Medtronic plc announced CE Mark approval for the MiniMed 780G system with Simplera Sync, a sensor that's half the size of its predecessors and features a streamlined insertion process.
These advancements emphasize the industry's commitment to user-centric design, accuracy, and broader global accessibility.
More Trending Reports by Transparency Market Research -
Hormonal Contraceptive Market - https://www.transparencymarketresearch.com/hormonal-contraceptives-market.html
Neuroscience Market - https://www.transparencymarketresearch.com/neuroscience-market.html
Multiplex Assays Market - https://www.transparencymarketresearch.com/multiplex-assays-market.html
Pharmaceutical Waste Management Market - https://www.transparencymarketresearch.com/pharmaceutical-waste-management-market.html
Hematocrit Test Devices Market - https://www.transparencymarketresearch.com/hematocrit-test-market.html
Cellulite Treatment Market - https://www.transparencymarketresearch.com/cellulite-treatment-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Continuous Glucose Monitoring Market Forecast 2035: Rising Diabetes Prevalence and Demand for Real-time Monitoring Propel Market Growth | Transparency Market Research, Inc here
News-ID: 4098190 • Views: …
More Releases from Transparency Market Research
Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion …
The global medium voltage fuse market is steadily transitioning from a traditional grid-protection niche to a strategic enabler of modern power systems. Rising investments in renewable energy integration, large-scale electrification programs, and infrastructure upgrades are reshaping demand patterns worldwide. Medium voltage fuses-typically rated between 1 kV and 35 kV-are no longer viewed as passive safety components; instead, they are increasingly recognized as critical assets for grid stability, asset protection, and…
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 …
The global lamination films market was valued at US$ 8,123.4 million in 2023 and is forecast to reach US$ 8,514.1 million in 2024. Over the forecast period from 2024 to 2032, the market is projected to expand at a compound annual growth rate (CAGR) of 4.6%, ultimately exceeding US$ 12,213.1 million by 2032. This steady growth trajectory reflects the indispensable role of lamination films in modern packaging ecosystems across food,…
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth …
The global curcumin market is entering a structurally strong growth phase, underpinned by rising consumer preference for natural, plant-based ingredients and increasing clinical validation of curcumin's antioxidant and anti-inflammatory properties. As consumers shift away from synthetic additives and chemical-based therapeutics, curcumin is emerging as a high-value bioactive ingredient across , functional foods, cosmetics, and pharmaceuticals. Premiumization trends in organic products, combined with regulatory validation from food safety authorities, are expected…
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - …
The global Hemoglobin A1c (HbA1c) Testing Devices Market was valued at US$ 1.4 Bn in 2023 and is projected to expand at a CAGR of 7.7% from 2024 to 2034, reaching more than US$ 3.3 Bn by the end of 2034. The market growth is primarily attributed to the increasing global burden of diabetes, growing awareness about disease management, and technological advancements in diagnostic devices.
Get a concise overview of key…
More Releases for CGM
Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days
Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions.
Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for…
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,…
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention.
In 2017, National Diabetes Services Scheme (NDSS) initiated by…
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)…
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes.
Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12
CMA CGM…
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market.
The global CGM market is undergoing a…
